Catalyst Wire Dossier Catalyst Wire Dossier

OROS Hydromorphone HCl Slow Release Tablets

hydromorphone hydrochloride · Alza Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OROS Hydromorphone HCl Slow Release Tablets, covering 2017-02-17 to 2017-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain [Phase 1]

See pricing